Åke Borg

56.4k total citations · 6 hit papers
275 papers, 18.7k citations indexed

About

Åke Borg is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Åke Borg has authored 275 papers receiving a total of 18.7k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Genetics, 115 papers in Molecular Biology and 97 papers in Cancer Research. Recurrent topics in Åke Borg's work include BRCA gene mutations in cancer (76 papers), Cancer Genomics and Diagnostics (71 papers) and Genomic variations and chromosomal abnormalities (49 papers). Åke Borg is often cited by papers focused on BRCA gene mutations in cancer (76 papers), Cancer Genomics and Diagnostics (71 papers) and Genomic variations and chromosomal abnormalities (49 papers). Åke Borg collaborates with scholars based in Sweden, United States and Denmark. Åke Borg's co-authors include Håkan Olsson, Markus Ringnér, Mårten Fernö, Johan Vallon‐Christersson, Lao H. Saal, Johan Staaf, Jorma Isola, Pär‐Ola Bendahl, Óskar Þór Jóhannsson and Helgi Sigurðsson and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Åke Borg

271 papers receiving 18.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-definition spatial transcriptomics for in situ tissue profiling

2019 705 citations Linnea Stenbeck, Ludvig Bergenstråhle et al. profile →
PIK3CA Mutations Correlate with Hormone Receptors, Node Metastasis, and ERBB2, and Are Mutually Exclusive with PTEN Loss in Human Breast Carcinoma

2005 681 citations Lao H. Saal, Åke Borg et al. Cancer Research profile →
Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma: HIF-2α promotes an aggressive phenotype

2006 594 citations Johan Vallon‐Christersson, Åke Borg et al. profile →
Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.

2001 540 citations Markus Ringnér, Lao H. Saal et al. PubMed profile →
Integrating spatial gene expression and breast tumour morphology via deep learning

2020 261 citations Bryan He, Ludvig Bergenstråhle et al. Nature Biomedical Engineering profile →
Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions

2021 205 citations Alma Andersson, Ludvig Larsson et al. profile →

Peers

Countries citing papers authored by Åke Borg

Since Specialization

Citations

This map shows the geographic impact of Åke Borg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Åke Borg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Åke Borg more than expected).

Fields of papers citing papers by Åke Borg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Åke Borg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Åke Borg. The network helps show where Åke Borg may publish in the future.

Co-authorship network of co-authors of Åke Borg

This figure shows the co-authorship network connecting the top 25 collaborators of Åke Borg. A scholar is included among the top collaborators of Åke Borg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Åke Borg. Åke Borg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Monitoring ctDNA dynamics in early breast cancer using a novel ultra-sensitive tumor-informed structural variant approach combining whole-genome sequencing and multiplex dPCR. 2024 ·Journal of Clinical Oncology ·Lao H. Saal, Niklas Loman, Yilun Chen, Miguel Alcaide, Christian Brueffer, (unknown), (unknown), (unknown), Anthony M. George, (unknown), (unknown), Siker Kimbung, Daniel Förnvik, (unknown), Gabriella Honeth, Karen Howarth, Åke Borg, Anna Ehinger, Martin Malmberg, Lisa Rydén	1
2	CDKN2A genetic testing in melanoma-prone families in Sweden in the years 2015–2020: implications for novel national recommendations 2021 ·Acta Oncologica ·(unknown), (unknown), (unknown), Gustav Silander, Åke Borg, Jenny Pettersson, Jan Lapins, K. Nielsen, Veronica Höiom, Hildur Helgadóttir	9
3	The spatial RNA integrity number assay for in situ evaluation of transcriptome quality 2021 ·Communications Biology ·Linda Kvastad, (unknown), Ludvig Larsson, (unknown), Alexander Stuckey, Linnea Stenbeck, Annelie Mollbrink, Margherita Zamboni, Jens P. Magnusson, (unknown), Alia Shamikh, (unknown), (unknown), Åke Borg, Lars Fugger, Monica Nistér, Joakim Lundeberg	21
4	The mutational landscape of the SCAN ‐B real‐world primary breast cancer transcriptome 2020 ·EMBO Molecular Medicine ·Christian Brueffer, (unknown), Christof Winter, Johan Vallon‐Christersson, Cecilia Hegardt, Jari Häkkinen, Anthony M. George, Yilun Chen, Anna Ehinger, Christer Larsson, Niklas Loman, Martin Malmberg, Lisa Rydén, Åke Borg, Lao H. Saal	42
5	Analysis of fusion transcripts indicates widespread deregulation of snoRNAs and their host genes in breast cancer 2020 ·International Journal of Cancer ·Helena Persson, Rolf Søkilde, Jari Häkkinen, Johan Vallon‐Christersson, Felix Mitelman, Åke Borg, Mattias Höglund, Carlos Rovira	10
6	Integrating spatial gene expression and breast tumour morphology via deep learning breakdown → 2020 ·Nature Biomedical Engineering ·Bryan He, Ludvig Bergenstråhle, Linnea Stenbeck, Abubakar Abid, Alma Andersson, Åke Borg, Jonas Maaskola, Joakim Lundeberg, James Zou	261
7	Functional characterization of novel germline TP53 variants in Swedish families 2019 ·Clinical Genetics ·Pedram Kharaziha, Sophia Ceder, (unknown), (unknown), (unknown), Stefanie Böhm, Sonia Laı́n, Åke Borg, Catharina Larsson, Klas G. Wiman, Emma Tham, Svetlana Bajalica‐Lagercrantz	9
8	Accuracy of self-reported family history of cancer, mutation status and tumor characteristics in patients with early onset breast cancer 2017 ·Acta Oncologica ·Annelie Augustinsson, Carolina Ellberg, Ulf Kristoffersson, Åke Borg, Håkan Olsson	17
9	Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma 2016 ·Cancer Research ·Katja Harbst, Martin Lauss, Helena Cirenajwis, Karolin Isaksson, Frida Rosengren, Therese Törngren, Anders Kvist, Maria C. Johansson, Johan Vallon‐Christersson, Bo Baldetorp, Åke Borg, Håkan Olsson, Christian Ingvar, Ana Carneiro, Göran Jönsson	77
10	Genome-wide DNA Methylation Analysis of Lung Carcinoma Reveals One Neuroendocrine and Four Adenocarcinoma Epitypes Associated with Patient Outcome 2014 ·Clinical Cancer Research ·Anna Karlsson, Mats Jönsson, Martin Lauss, Hans Brunnström, Per Jönsson, Åke Borg, Göran Jönsson, Markus Ringnér, Maria Planck, Johan Staaf	82
11	Cancer-Associated Fibroblasts Expressing CXCL14 Rely upon NOS1-Derived Nitric Oxide Signaling for Their Tumor-Supporting Properties 2014 ·Cancer Research ·Martin Augsten, Elin Sjöberg, Oliver Frings, Sabine U. Vorrink, Jeroen Frijhoff, Eleonor Olsson, Åke Borg, Arne Östman	116
12	Mutual Exclusivity Analysis of Genetic and Epigenetic Drivers in Melanoma Identifies a Link Between p14ARF and RARβ Signaling 2013 ·Molecular Cancer Research ·Christina Dahl, Claus Christensen, Göran Jönsson, (unknown), (unknown), Åke Borg, Graham Pawelec, Per Guldberg	21
13	Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma 2012 ·Clinical Cancer Research ·Katja Harbst, Johan Staaf, Martin Lauss, Anna Karlsson, Anna Måsbäck, Iva Johansson, Pär‐Ola Bendahl, Johan Vallon‐Christersson, Therese Törngren, Henrik Ekedahl, Jürgen Geisler, Mattias Höglund, Markus Ringnér, Lotta Lundgren, Karin Jirström, Håkan Olsson, Christian Ingvar, Åke Borg, Hensin Tsao, Göran Jönsson	72
14	Identification of New MicroRNAs in Paired Normal and Tumor Breast Tissue Suggests a Dual Role for the ERBB2/Her2 Gene 2011 ·Cancer Research ·Helena Persson, Anders Kvist, Natalia Rego, Johan Staaf, Johan Vallon‐Christersson, Lena Luts, Niklas Loman, Göran Jönsson, Hugo Naya, Mattias Höglund, Åke Borg, Carlos Rovira	158
15	Gene Expression Profiling–Based Identification of Molecular Subtypes in Stage IV Melanomas with Different Clinical Outcome 2010 ·Clinical Cancer Research ·Göran Jönsson, Christian Busch, Stian Knappskog, Jürgen Geisler, Hrvoje Miletić, Markus Ringnér, Johan R. Lillehaug, Åke Borg, Per Eystein Lønning	189
16	Estrogen Receptor β Expression Is Associated with Tamoxifen Response in ERα-Negative Breast Carcinoma 2007 ·Clinical Cancer Research ·Sofia K. Gruvberger-Saal, Pär‐Ola Bendahl, Lao H. Saal, Mervi Laakso, Cecilia Hegardt, P. Edén, Carsten Peterson, Per Malmström, Jorma Isola, Åke Borg, Mårten Fernö	154
17	Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles 2004 ·Molecular Cancer Therapeutics ·Sofia K. Gruvberger-Saal, Patrik Edén, Markus Ringnér, Bo Baldetorp, Gunilla Chebil, Åke Borg, Mårten Fernö, Carsten Peterson, Paul S. Meltzer	25
18	First BRCA1 and BRCA2 Gene Testing Implemented in the Health Care System of Stockholm 2001 ·Genetic Testing ·Brita Arver, Åke Borg, Annika Lindblom	10
19	The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14. 1996 ·PubMed ·Ioannis Panagopoulos, Nikos Pandis, (unknown), Carl Petersson, Fredrik Mertens, Åke Borg, Ulf Kristoffersson, Felix Mitelman, Pierre Åman	59
20	HER-2/neu amplification predicts poor survival in node-positive breast cancer. 1990 ·PubMed ·Åke Borg, Amol Tandon, Helgi Sigurðsson, Gary M. Clark, Mårten Fernö, Suzanne A.W. Fuqua, D. Killander, (unknown)	393

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact